A Randomized Phase 3 Study, Sinus-52, Evaluating the Efficacy and Safety of Dupilumab in Patients with Severe Chronic Rhinosinusitis with Nasal Polyps

Publication date: February 2019

Source: Journal of Allergy and Clinical Immunology, Volume 143, Issue 2, Supplement

Author(s): Claus Bachert, Martin Desrosiers, Joaquim Mullol, Peter W. Hellings, Anders Cervin, Lawrence Sher, John V. Bosso, Stella E. Lee, Jorge F. Maspero, Shigeharu Fujieda, Shoji Matsune, Xin Lu, Chunpeng Fan, Steven Draikiwicz, Nikhil Amin, Siddhesh Kamat, Asif Khan, Gianluca Pirozzi, Neil M.H. Graham, Marcella Ruddy

http://bit.ly/2MOLUzy